Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Aleniglipron

GSBR-1290

Gasherbrum Bio, Inc · Phase 2 · Completed · Enrollment 58

NCT07400588

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Arm 1: Participants will receive aleniglipron administered orallyn/rn/rn/rn/r
Arm 2: Participants will receive a placebo administered orallyn/rn/rn/rn/r

Not shown

  • Arm 1: Participants will receive aleniglipron administered orally: endpoint not reported
  • Arm 2: Participants will receive a placebo administered orally: endpoint not reported